N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide

C22H21F6N5O5S — CID 166713089

IUPACN-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide
SMILESC[C@@H](NC(=O)C(=O)N1CC2(COc3c(cn(C)c3C(=O)Nc3ccc(F)c(C(F)F)c3)S(=O)N2)C1)C(F)(F)F
InChIInChI=1S/C22H21F6N5O5S/c1-10(22(26,27)28)29-19(35)20(36)33-7-21(8-33)9-38-16-14(39(37)31-21)6-32(2)15(16)18(34)30-11-3-4-13(23)12(5-11)17(24)25/h3-6,10,17,31H,7-9H2,1-2H3,(H,29,35)(H,30,34)/t10-,39?/m1/s1
InChIKeyVGIWWVYDNPDJCU-JIZNIFSOSA-N
MW581.50 g/mol
LogP2.01
Rot. Bonds4

About N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide

N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide (PubChem CID 166713089) has the molecular formula C22H21F6N5O5S and a molecular weight of 581.50 g/mol. Its IUPAC name is N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide.

Molecular Properties

Compound NameN-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide
PubChem CID166713089
Molecular FormulaC22H21F6N5O5S
Molecular Weight581.50 g/mol
Exact Mass581.12
IUPAC NameN-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide
SMILESC[C@@H](NC(=O)C(=O)N1CC2(COc3c(cn(C)c3C(=O)Nc3ccc(F)c(C(F)F)c3)S(=O)N2)C1)C(F)(F)F
InChIInChI=1S/C22H21F6N5O5S/c1-10(22(26,27)28)29-19(35)20(36)33-7-21(8-33)9-38-16-14(39(37)31-21)6-32(2)15(16)18(34)30-11-3-4-13(23)12(5-11)17(24)25/h3-6,10,17,31H,7-9H2,1-2H3,(H,29,35)(H,30,34)/t10-,39?/m1/s1
InChIKeyVGIWWVYDNPDJCU-JIZNIFSOSA-N
XLogP2.01
TPSA121.77 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500581.50
LogP ≤ 52.01
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide?
The IUPAC name of N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide (CID 166713089) is N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide.
What is the SMILES notation for N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide?
The canonical SMILES for N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide is C[C@@H](NC(=O)C(=O)N1CC2(COc3c(cn(C)c3C(=O)Nc3ccc(F)c(C(F)F)c3)S(=O)N2)C1)C(F)(F)F.
What is the InChIKey of N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide?
The InChIKey is VGIWWVYDNPDJCU-JIZNIFSOSA-N. The full InChI is InChI=1S/C22H21F6N5O5S/c1-10(22(26,27)28)29-19(35)20(36)33-7-21(8-33)9-38-16-14(39(37)31-21)6-32(2)15(16)18(34)30-11-3-4-13(23)12(5-11)17(24)25/h3-6,10,17,31H,7-9H2,1-2H3,(H,29,35)(H,30,34)/t10-,39?/m1/s1.
What are the key properties of N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide?
N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide has a molecular weight of 581.50 g/mol, XLogP of 2.01, 4 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(difluoromethyl)-4-fluorophenyl]-7-methyl-1-oxo-1'-[2-oxo-2-[[(2R)-1,1,1-trifluoropropan-2-yl]amino]acetyl]spiro[2,4-dihydropyrrolo[3,4-b][1,4,5]oxathiazepine-3,3'-azetidine]-6-carboxamide is sourced from PubChem (CID 166713089), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).